tiprankstipranks
Optimi Health (TSE:OPTI)
CNQX:OPTI

Optimi Health (OPTI) Income Statement

28 Followers

Optimi Health Income Statement

Last quarter (Q2 2024), Optimi Health's total revenue was C$187.96K, an increase of 168.05% from the same quarter last year. In Q2, Optimi Health's net income was C$-2.69M. See Optimi Health’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Sep 23Sep 22Sep 21Sep 20
Total Revenue
C$ 356.46KC$ 181.09KC$ 80.72K-C$ 0.00
Cost of Revenue
C$ 270.49KC$ 19.14KC$ 26.80K--
Gross Profit
C$ 85.97KC$ 200.23KC$ 53.92K--
Operating Expense
C$ 6.99MC$ 5.47MC$ 7.44MC$ 6.06MC$ 166.57K
Operating Income
C$ -6.91MC$ -5.44MC$ -7.39MC$ -6.06MC$ -166.57K
Net Non Operating Interest Income Expense
C$ -231.67KC$ 92.70KC$ 38.95KC$ -35.85KC$ -2.65K
Other Income Expense
C$ -134.01KC$ -14.96K---
Pretax Income
C$ -7.00MC$ -5.19MC$ -7.35MC$ -6.02MC$ -169.22K
Tax Provision
-----
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
C$ -7.00MC$ -5.19MC$ -7.35MC$ -6.02MC$ -169.22K
Basic EPS
C$ -0.07C$ 0.06C$ -0.09C$ -0.12C$ >-0.01
Diluted EPS
C$ -0.07C$ 0.06C$ -0.09C$ -0.12C$ >-0.01
Basic Average Shares
C$ 353.29MC$ 86.98MC$ 77.94MC$ 51.92MC$ 69.06M
Diluted Average Shares
C$ 353.29MC$ 86.98MC$ 77.94MC$ 51.92MC$ 69.06M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
C$ 7.26MC$ 5.49MC$ 7.47MC$ -6.06MC$ 166.57K
Net Income From Continuing And Discontinued Operation
C$ -7.00MC$ -5.19MC$ -7.35MC$ -6.02MC$ -169.22K
Normalized Income
C$ -6.21MC$ -3.80MC$ -5.40MC$ -4.42MC$ -169.22K
Interest Expense
----C$ 2.65K
EBIT
C$ -6.78MC$ -5.15MC$ -7.32MC$ -6.00MC$ -166.57K
EBITDA
C$ -6.09MC$ -4.42MC$ -7.03MC$ -5.95MC$ -161.14K
Currency in CAD

Optimi Health Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis